AFPTM / 3000730MC

Test Code AFPTM / 3000730MC 
Methodology Chemiluminescent Immunoassay 
Description Useful as an aid in the management of patients with germ cell tumors.

NOTE: This test, when ordered on Medicare patients, is subject to the National Coverage Determination (NCD) policy "Alpha-fetoprotein". Please verify that the diagnosis code (ICD-9) you have chosen demonstrates medical necessity for the test as documented in the physician's patient record. The CMS web site or the NorDx Limited Coverage Documentation Guide are available to assist you with this verification. A properly executed Advance Beneficiary Notice (ABN) must be submitted with the specimen if medical necessity is not demonstrated by the ICD-9 code chosen or if the frequency of a frequency-limited test is unknown. 

Specimen Amniotic fluid should not be sent because this test is only used as a tumor marker.

Draw blood in a plain, red-top tube(s) or a serum gel tube(s). Spin down and send 1.0 mL (minimum 0.5 mL) of serum frozen in a screw capped plastic vial. 

Reference Values <6.7 ng/mL
Warning: Reference values are for non-pregnant subjects only; pregnancy may cause elevated AFP values.
Serum markers are not specific for malignancy and values may vary by method. 
Analytic Time 1 Day 
Day(s) Test Set Up Monday through Friday 
CPT Code(s) 82105